Literature DB >> 18776260

Transition state analogues in quorum sensing and SAM recycling.

Vern L Schramm1, Jemy A Gutierrez, Grace Cordovano, Indranil Basu, Chandan Guha, Thomas J Belbin, Gary B Evans, Peter C Tyler, Richard H Furneaux.   

Abstract

Transition state structures can be derived from kinetic isotope effects and computational chemistry. Molecular electrostatic potential maps of transition states serve as blueprints to guide synthesis of transition state analogue inhibitors of target enzymes. 5'- Methylthioadenosine phosphorylase (MTAP) functions in the polyamine pathway by recycling methylthioadenosine (MTA) and maintaining cellular S-adenosylmethionine (SAM). Its transition state structure was used to guide synthesis of MT-DADMe-ImmA, a picomolar inhibitor that shows anticancer effects against solid tumors. Biochemical and genomic analysis suggests that MTAP inhibition acts by altered DNA methylation and gene expression patterns. A related bacterial enzyme, 5'-methylthioadenosine nucleosidase (MTAN), functions in pathways of quorum sensing involving AI-1 and AI-2 molecules. Transition states have been solved for several bacterial MTANs and used to guide synthesis of powerful inhibitors with dissociation constants in the femtomolar to picomolar range. BuT-DADMe-ImmA blocks quorum sensing in Vibrio cholerae without changing bacterial growth rates. Transition state analogue inhibitors show promise as anticancer and antibacterial agents.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18776260      PMCID: PMC2725438          DOI: 10.1093/nass/nrn038

Source DB:  PubMed          Journal:  Nucleic Acids Symp Ser (Oxf)        ISSN: 0261-3166


  7 in total

Review 1.  Enzymatic transition states: thermodynamics, dynamics and analogue design.

Authors:  Vern L Schramm
Journal:  Arch Biochem Biophys       Date:  2005-01-01       Impact factor: 4.013

2.  Picomolar inhibitors as transition-state probes of 5'-methylthioadenosine nucleosidases.

Authors:  Jemy A Gutierrez; Minkui Luo; Vipender Singh; Lei Li; Rosemary L Brown; Gillian E Norris; Gary B Evans; Richard H Furneaux; Peter C Tyler; Gavin F Painter; Dirk H Lenz; Vern L Schramm
Journal:  ACS Chem Biol       Date:  2007-11-20       Impact factor: 5.100

Review 3.  Enzymatic transition state theory and transition state analogue design.

Authors:  Vern L Schramm
Journal:  J Biol Chem       Date:  2007-08-09       Impact factor: 5.157

4.  Second generation transition state analogue inhibitors of human 5'-methylthioadenosine phosphorylase.

Authors:  Gary B Evans; Richard H Furneaux; Dirk H Lenz; Gavin F Painter; Vern L Schramm; Vipender Singh; Peter C Tyler
Journal:  J Med Chem       Date:  2005-07-14       Impact factor: 7.446

5.  Femtomolar transition state analogue inhibitors of 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase from Escherichia coli.

Authors:  Vipender Singh; Gary B Evans; Dirk H Lenz; Jennifer M Mason; Keith Clinch; Simon Mee; Gavin F Painter; Peter C Tyler; Richard H Furneaux; Jeffrey E Lee; P Lynne Howell; Vern L Schramm
Journal:  J Biol Chem       Date:  2005-03-04       Impact factor: 5.157

Review 6.  Pharmacology and mechanism of action of forodesine, a T-cell targeted agent.

Authors:  Varsha Gandhi; Kumudha Balakrishnan
Journal:  Semin Oncol       Date:  2007-12       Impact factor: 4.929

7.  A transition state analogue of 5'-methylthioadenosine phosphorylase induces apoptosis in head and neck cancers.

Authors:  Indranil Basu; Grace Cordovano; Ishita Das; Thomas J Belbin; Chandan Guha; Vern L Schramm
Journal:  J Biol Chem       Date:  2007-06-04       Impact factor: 5.157

  7 in total
  16 in total

1.  Role of methylthioadenosine/S-adenosylhomocysteine nucleosidase in Vibrio cholerae cellular communication and biofilm development.

Authors:  Anisia J Silva; William B Parker; Paula W Allan; Julio C Ayala; Jorge A Benitez
Journal:  Biochem Biophys Res Commun       Date:  2015-04-04       Impact factor: 3.575

2.  Continuous Fluorescence Assays for Reactions Involving Adenine.

Authors:  Ross S Firestone; Scott A Cameron; Peter C Tyler; Rodrigo G Ducati; Adam Z Spitz; Vern L Schramm
Journal:  Anal Chem       Date:  2016-11-11       Impact factor: 6.986

Review 3.  Bacterial quorum sensing: its role in virulence and possibilities for its control.

Authors:  Steven T Rutherford; Bonnie L Bassler
Journal:  Cold Spring Harb Perspect Med       Date:  2012-11-01       Impact factor: 6.915

Review 4.  Exploiting quorum sensing to confuse bacterial pathogens.

Authors:  Breah LaSarre; Michael J Federle
Journal:  Microbiol Mol Biol Rev       Date:  2013-03       Impact factor: 11.056

Review 5.  Targeting virulence: can we make evolution-proof drugs?

Authors:  Richard C Allen; Roman Popat; Stephen P Diggle; Sam P Brown
Journal:  Nat Rev Microbiol       Date:  2014-04       Impact factor: 60.633

Review 6.  Regulatory Mechanisms of the LuxS/AI-2 System and Bacterial Resistance.

Authors:  Yang Wang; Baobao Liu; Daniel Grenier; Li Yi
Journal:  Antimicrob Agents Chemother       Date:  2019-09-23       Impact factor: 5.191

Review 7.  Quorum sensing by farnesol revisited.

Authors:  Melanie Polke; Ilse D Jacobsen
Journal:  Curr Genet       Date:  2017-02-28       Impact factor: 3.886

Review 8.  Methylthioadenosine/S-adenosylhomocysteine nucleosidase, a critical enzyme for bacterial metabolism.

Authors:  Nikhat Parveen; Kenneth A Cornell
Journal:  Mol Microbiol       Date:  2010-11-18       Impact factor: 3.501

9.  Assessment of methylthioadenosine/S-adenosylhomocysteine nucleosidases of Borrelia burgdorferi as targets for novel antimicrobials using a novel high-throughput method.

Authors:  Kenneth A Cornell; Shekerah Primus; Jorge A Martinez; Nikhat Parveen
Journal:  J Antimicrob Chemother       Date:  2009-04-17       Impact factor: 5.790

10.  Acyclic phosph(on)ate inhibitors of Plasmodium falciparum hypoxanthine-guanine-xanthine phosphoribosyltransferase.

Authors:  Keith Clinch; Douglas R Crump; Gary B Evans; Keith Z Hazleton; Jennifer M Mason; Vern L Schramm; Peter C Tyler
Journal:  Bioorg Med Chem       Date:  2013-03-05       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.